In the continuous search for new antiinflammatory agents from natural products, dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) extracts of Ipomea fistulosa leaves were evaluated for inhibition of production of nitric oxide (NO), interleukin 1beta (IL-1β) and tumor necrosis factor alpha (TNF-α) in lipopolysaccharide (LPS) stimulated J774A.1 cells. Among the tested extracts, the ethyl acetate (EtOAc) extract was found to be most active and activity based fractionation of this extract by column chromatography led to the identification of seven compounds for the first time from this plant. Furthermore, 3,4-dimethoxy cinnamic acid (1) exhibited two folds more potent inhibition of LPS-induced NO production (IC 50 = 10.7 μg/mL) as compared with the standard, L-NAME (IC 50 =19.8 μg/mL). The present study supports the use of Ipomea fistulosa leaves for the treatment of inflammation.
Inflammation is caused by pernicious stimuli such as chemicals or physical injury, when damage to tissues and cells occurs by pathogens. Chronic inflammation relates to various chronic human conditions and diseases, including cancer, atherosclerosis, arthritis, allergy and autoimmune diseases [1a] . Homeostatic and pathologic stimuli lead to the release of nitric oxide (NO) from a variety of cells, which exhibit an important regulatory role in a variety of inflammatory conditions [1b] . Multifunctional cytokine, known as tumor necrosis factor-alpha (TNF-α), is normally involved in the regulation of various cellular and biological processes such as proliferation, apoptosis, immune function, cell differentiation and energy metabolism [1c] .
Ipomea fistulosa Mart. ex Choisy (Convolvulaceae) possesses immunomodulatory [2] , antimicrobial [3] , anti-HIV [4a] , antifungal [4b] and neuromuscular blocking activity [5a] . Recently, the chloroform fraction from flowers of Ipomoea carnea demonstrated anti-inflammatory effects in the toluene diisocyanate-induced inflammation model in Wistar rats [5b] . With the continuous efforts towards finding new anti-inflammatory agents based on natural products [6a-d] , we performed bioassay guided fractionation of I. fistulosa leaves using triple assay guides (inhibition of the production of NO, IL-1β and TNF-α) in J774A.1 cells. The cytotoxicity effects of the tested samples were also evaluated using MTT assay. Our preliminary screening of various extracts of I. fistulosa leaves revealed that the anti-inflammatory activity was mainly concentrated in the EtOAc extract (IC 50 =12.1, 23.2 and 62.1 μg/mL towards NO, TNF-α and IL-1β inhibition, respectively, in J774A.1 cells, Table 1 ). This prompted us to isolate and identify the constituents present in it. The EtOAc extract was fractionated by vacuum liquid chromatography (VLC) into four major fractions (A to D). Upon testing, fraction B was found to have the highest activity, followed by C towards inhibition of proinflammatory mediators ( Table 2) . Interestingly, in the case of nitric oxide, inhibition by all fractions (IC 50 = < 18 μg/mL) was more profound than that of the specific nitric oxide inhibitor L-NAME (IC 50 = 19.8 μg/mL). Also, at concentrations of 20 μg/mL, fractions B and C were found to inhibit 19-54% of IL-1β and TNF-α release a Cell viability was measured at a concentration of 100 µg/mL; b standards (IC 50 in µg/mL); data shown as mean ± S.D. of three different experiments in duplicate/triplicate Table 2 : In vitro anti-inflammatory activity of fractions from EtOAc extract of I. fistulosa leaves and reference compounds in J774A.1 cells a standards (IC 50 in µg/mL); data shown as mean ± S.D. of three different experiments in duplicates/triplicates in macrophages. 3,4-Dimethoxy cinnamic acid (1) isolated from fraction C was found to exhibit two fold greater inhibition of NO, with half maximal concentration of 10.7 μg/mL, compared with L-NAME, while inhibiting by 59.2 and 36.4% TNF-α and IL-1β production, respectively, at a concentration of 20 μg/mL. Beside 1, other cinnamoids such as cinnamic acid (2), ferulic acid (3), p-coumaric acid (4), caffeic acid (5) and chlorogenic acid (6) identified in fraction C might be contributing to the antiinflammatory effects of this fraction. Similarly, stigmasterol (7), identified from fraction B by dereplication, might be responsible for the antiinflammatory activity of this fraction [5b,6a] . All the tested samples were found to be non-cytotoxic (cell viability >75 %). To the best of our knowledge, this is the first report of the identification of such cinnamoids, except chlorogenic acid (6) Patel et al. steroid present in the leaves of this plant are mainly responsible for the anti-inflammatory effects, which are partially mediated by inhibition of proinflammatory mediators viz. NO, IL-1β and TNF-α.
Experimental
General: MS, ThermoQuest mass spectrometer; NMR, Bruker DPX 400. All the extracts were concentrated using a vacuum rotary evaporator.Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), phosphate buffered saline (PBS), 3-(4,5dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazoliumbromide (MTT), antibiotic solution and other chemicals for the biological experiments were purchased from Hi-media Limited (Mumbai, India). Lipopolysaccharide (Escherichia coli 026:B6) (LPS), dimethyl sulfoxide (DMSO), dexamethasone, curcumin, L-N Gnitroarginine methyl ester (L-NAME) and modified Griess reagent were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Mouse TNF-α and IL-1β ELISA kits were purchased from Krishgen Biosystems (Mumbai, India).
Plant materials:
Leaves of Ipomea fistulosa were collected from the adjoining areas of NIPER, SAS Nagar, Punjab, India and were authenticated (Herbarium no., and deposited in the Department of Natural Products (DNP), NIPER. The plant materials were cleaned and then dried in the shade for 15 days, followed by pulverization and size reduction to 20-30 mesh before extraction.
Bioactivity guided fractionation of Ipomea fistulosa leaves:
Shade dried and powdered (20-30 mesh) leaves of Ipomea fistulosa (3.28 Kg) were successively extracted in a macerator (3 x 6 L each) with hexanes (Hex), dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) and concentrated to dryness in vacuo on a rotary evaporator to yield Hex (65.9 g), DCM (64.6), EtOAc (100.9 g) and MeOH (112.7 g) extracts, respectively. The EtOAc extract (97.9 g) was subjected to vacuum liquid chromatography (VLC) on silica gel (340g, 100-200 mesh) and eluted gradiently, starting with Hex-EtOAc (100:0 to 0:100) and from EtOAc-MeOH (100:0 to 0:100).
Each fraction of 500 mL was collected and, based on the TLC pattern, fractions were pooled into 4 main fractions (A to D) and subsequently tested for pro-inflammatory inhibition against J774A.1 cells. Fraction B and C were found to produce prominent inhibition of NO, IL-1β and TNF-α and hence subjected to further fractionation. Fraction C (58.2 g) was subjected to CC on silica gel (125 g, 230-400 mesh), eluted using a gradient of hexanes-ethyl acetate (7:3 to 0:1), providing 4 main sub-fractions (Ca to Cd). Cd, on further purification, yielded 3,4-dimethoxy cinnamic acid (1, 40 mg) [7] .
Five cinnamoids namely cinnamic acid (2) , ferulic acid (3), pcoumaric acid (4), caffeic acid (5) and chlorogenic acid (6) were dereplicated by silica gel 60 F 254 TLC from fractions Ca to Cc (R f values: cinnamic acid-0.75, ferulic acid-0.68, p-coumaric acid-0.63, caffeic acid-0.42, and chlorogenic acid-0.08. Mobile phasechloroform:methanol:formic acid=8:1. 5:0.5, v/v/v, at 254 nm) . Similarly, fraction B, on dereplication over silica gel 60 F 254 TLC, was found to contain mainly stigmasterol (7) (R f -0.40, mobile phase-hexanes:ethyl acetate=9.0:1.0 v/v, detection with anisaldehyde-sulfuric acid reagent).
Cell culture, cell viability and nitric oxide release assay: J774A.1 cells, obtained from the National Centre for Cell Sciences (NCCS, Pune, India), were cultured in 250 mL culture flasks containing DMEM supplemented with heat inactivated 10% FBS, 10,000 units/mL pencillin and 10 ng/mL streptomycin in 0.9% saline, in a CO 2 incubator (5% CO 2 in air) at 37°C. Cell viability was assessed by MTT assay and NO release in the culture medium was quantified using the Griess reaction, as previously reported by us [6a] .
Assays for measurement of TNF-α and IL-1β:
Estimation of proinflammatory mediators in supernatants was performed by sandwich immunoassays using the supplier's protocol (Krishgen Biosystems, Mumbai, India) [6a] . Briefly, cells were subjected to different concentrations of the test samples for 1 h, and then induced with 1µg/mL of LPS (Escherichia coli 026:B6) in a 96 well microtitre plate. In the case of TNF-α and IL-1β, the cells were further incubated for 6 h and 12 h, respectively, and cytokine level in supernatants were measured.
Data presentation and analysis:
Results are shown as the mean ± SD of 3 different experiments in duplicate/triplicate. Statistical analysis was performed by One-Way ANOVA followed by a Dunnett's post test (commercially available software SigmaStat 3.5) with a level of p < 0.05 for statistical significance.
